Indietro

IDEXX Laboratories Inc

Ticker: IDXX ISIN: US45168D1046
Aggiungi al portafoglio Analisi del portafoglio in 2min
Stock Large-cap High beta Trading above 200-day average Near 52-week high
Capitalizzazione
34,63 Mld $
P/E
40,82
Forward P/E
37,04
Profit margin
22,53%
Revenue growth QoQ
6,60%
Beta
1,36
554,99 $ 1,82%
Prezzo al 2026-08-28 · NASDAQ

Performance per periodo

Rendimenti cumulativi
1 Month -0,68%
6 Months -12,83%
1 Year -14,23%
5 Years -4,18% p.a.-19,21%
10 Years +17,30% p.a.+392,54%
Since inception +19,95% p.a.+9.314,59%
Rendimenti per anno
YTD -17,97%
2025 +63,63%
2024 -25,51%
2023 +36,06%
2022 -38,04%
2021 +31,73%

Key stats

Market cap
34,63 Mld
P/E
40,82
Beta
1,36
52-week range
398.50 - 583.39
50-day MA
423,43
200-day MA
473,52
Section 1

Business overview

Company profile data from fundamentals.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Sector Healthcare
Industry Diagnostics & Research
Country United States
Exchange NASDAQ
Section 2

Financial quality

Above-average volatility

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 59,42%
ROA 22,79%
Profit margin 22,53%
Operating margin 37,46%
PEG ratio 4,41
Revenue/share TTM 46,45
Revenue TTM 3,84 Mld
EBITDA 1,30 Mld
Gross profit TTM 2,33 Mld
Beta 1,36

Valuation

Trailing P/E 40,82
Forward P/E 37,04
P/B 21,19
P/S 9,01
EV/EBITDA 27,93
EV/Revenue 9,10

ESG Scores

Total ESG 29,8
Environment 9,9
Social 14,4
Governance 17,9
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 10,73
Quarterly earnings growth 10,70%
Revenue TTM 3,84 Mld
Reported quarters 118
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Forward annual div. yield 0,00%
Split factor 2:1
Last split date 2015-06-16
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price 478,62 $
Analyst rating 3.6429

Ownership & short interest

Shares outstanding 81,88 Mln
Shares float 80,97 Mln
Institutional ownership 95,14%
Insider ownership 94,30%
Short ratio 2,57
Short % of float 2,35%

Details

Instrument metadata and source update timestamps.

Symbol IDXX
Name IDEXX Laboratories Inc
Asset type STOCK
Exchange NASDAQ
Currency USD
ISIN US45168D1046
Country USA
Code + exchange IDXX.NASDAQ
Fundamentals updated 2025-01-16

Le informazioni fornite su questa piattaforma hanno solo scopo informativo e non devono essere considerate consulenza finanziaria o di investimento. Insightfolio non fornisce consulenza d'investimento, raccomandazioni personalizzate o indicazioni relative all'acquisto, alla detenzione o alla vendita di strumenti finanziari. Gli strumenti e i contenuti sono destinati esclusivamente a finalita educative e non sono adattati alle circostanze individuali, alle esigenze finanziarie o agli obiettivi personali.

Insightfolio non si assume alcuna responsabilita per l'accuratezza, la completezza o l'affidabilita delle informazioni presentate. Gli utenti sono gli unici responsabili della verifica delle informazioni e dell'assunzione di decisioni indipendenti basate sulla propria ricerca e su un'attenta valutazione. L'uso della piattaforma non deve sostituire la consulenza di professionisti finanziari qualificati.

Gli investimenti comportano rischi. Gli utenti devono essere consapevoli che il valore degli investimenti puo variare e che i rendimenti passati non sono indicativi di risultati futuri. Le decisioni di investimento devono basarsi sugli obiettivi finanziari personali, sulla tolleranza al rischio e su una valutazione indipendente delle informazioni rilevanti.

Insightfolio non approva ne garantisce l'idoneita di alcun prodotto finanziario, titolo o strategia specifica. Eventuali proiezioni, previsioni o scenari ipotetici presentati sulla piattaforma hanno solo scopo illustrativo e non costituiscono garanzia di risultati futuri.

Accedendo ai servizi, alle informazioni o ai contenuti offerti da Insightfolio, gli utenti riconoscono e accettano i presenti termini di esclusione di responsabilita. Se non accetti questi termini, ti invitiamo a non utilizzare la piattaforma.

Instrument logos provided by Elbstream.